🍁 Proudly Canadian · Toronto, Ontario · Health Canada Certified

📍 Toronto University Hospital, Ontario

Helping Lives Through
the Power of Light

AdvanceMedPro brings pain-free, non-invasive diagnostics to Canadian hospitals and homes. No needles. No incisions. Just light — reading what your body needs.

Discover Our Technology Book a Demo

47+ Biomarkers
Detected

5 Breakthrough
Patents

98% Diagnostic
Accuracy

0 Invasive
Procedures

Our Purpose

Medicine Should
Never Hurt

We believe every Canadian deserves diagnostics that are accurate, fast, and completely painless. AdvanceMedPro was built for patients first — not just practitioners.

Patient-First Design

Every device is designed around comfort. No prep, no recovery, no anxiety — just answers.

Built for Canadian Healthcare

Validated in Canadian hospitals, registered with Health Canada, and designed for our healthcare system.

Results in Seconds, Not Hours

Live biomarker data streams to clinical dashboards instantly — enabling faster, better interventions.

Wearable & Remote Care

Patients monitored at home with hospital-grade precision — reducing admissions by up to 60%.

Clinician reviewing non-invasive scan results

QuantaFlux™ Active Scan

0.4s Scan Time

47 Biomarkers

0 Needles Used

98% Accuracy

How It Works

Diagnosis Without Discomfort

From scan to results in under a minute — completely painless, completely non-invasive.

Light Applied

A gentle multi-spectral scan is applied to the skin. No contact needed — just precise light.

AI Analysis

Our AI — trained on 2.4M+ patient scans — decodes spectral signatures into 47 live biomarkers.

Instant Results

Clinicians receive precise, actionable data in under 3 seconds, streamed live to their dashboards.

Proprietary Technologies

Five World Firsts.
One Mission.

Each technology was developed exclusively by AdvanceMedPro to open new frontiers in painless care.

QuantaFlux Spectral Mapping

QSM · Patent Pending CA-2024-0891

Quantum dot arrays map cellular oxygen metabolism at the mitochondrial level — through intact skin — with sub-micron resolution.

Quantum Dots O₂ Metabolism World First

BioLumin Resonance Imaging

BLRI · Patent Pending CA-2024-0892

Detects tumour microenvironments and inflammatory cascades externally — no contrast agents, no radiation, just light.

BRET Principle Oncology World First

ChromaDerm Analysis

CDA · Patent Pending CA-2024-0893

A single 0.4-second light pass simultaneously identifies 47 biomarkers — glucose, cortisol, clotting factors, hydration, and more.

47 Biomarkers AI Spectral World First

PhoTissue Wave Therapy

PWT · Patent Pending CA-2024-0894

Adaptive near-infrared waveforms diagnose tissue damage and trigger healing cascades simultaneously — one device for both.

NIR Therapy Tissue Repair World First

NeuroPulse Optical Mapping

NPOM · Patent Pending CA-2024-0895

A non-contact photonic scanner maps neural activity through the intact skull with millimetre precision — no MRI required.

Neurology Non-Contact World First

Full Technology Details

From Canadian Clinicians

Doctors Who've Seen It Work

Frontline clinicians at Canada's leading hospitals share what this technology means for their patients.

The ChromaDerm device replaced seven separate blood tests in our ward. Results in seconds instead of hours — patients are amazed, and frankly, so are we.

Dr. Rajani Mehta

Chief of Endocrinology, Toronto University Hospital

NeuroPulse has transformed how we monitor post-surgical brain trauma patients. Continuous, non-invasive cortical mapping at the bedside — extraordinary science.

Prof. David Liang

Director of Neurosurgery, UHN Toronto

BLRI caught a recurrence three weeks before it appeared on PET scans. That's not incremental improvement — that's a paradigm shift in how we care for patients.

Dr. Simone Carvalho

Oncology Research Lead, Princess Margaret Cancer Centre

Helping Lives Throughthe Power of Light

Medicine ShouldNever Hurt